Image
|
Figure Caption
Fig. S2
Smoothened agonist treatment does not alter the ciliopathy-like phenotypes in giantin morphants. (A) Quantification of phenotypes observed (48 hpf). Note, no difference is seen with 1 ng p53 morpholino co-injection in all conditions. (B) Gli::mCherry expression was reduced in somites after SANT1 treatment, but not in SAG-treated individuals (48 hpf). SAG: smoothened agonist, SANT1: smoothened antagonist 1.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Biol. Open